The findings displayed that ILCs were considerably altered at diagnosis in relation to the number, subsets, and activity, while ILC normality was in part recuperated in subjects responsive to treatment, proposing that ILC dysregulation characterizes AML regardless of chemotherapy. The gene discussed is CCL27; the disease is acute myeloid leukemia.